Institutional investors hold a majority ownership of AGN through the 92.72% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended December 2016, these large investors purchased a net $22.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ATALANTA SOSNOFF MANAGEMENT LLC Bought 108.0 Thousand shares of Allergan
VANGUARD INVESTMENTS AUSTRALIA L... Bought 106.1 Thousand shares of Allergan
BOSTON MANAGEMENT & RESEARCH Bought 41.8 Thousand shares of Allergan